Matias Gonçalo, Taylor Robert, Haguinet François, Schuck-Paim Cynthia, Lustig Roger, Shinde Vivek
GlaxoSmithKline Vaccines, Wavre, Belgium.
Influenza Other Respir Viruses. 2014 Sep;8(5):507-15. doi: 10.1111/irv.12258. Epub 2014 Jun 27.
Influenza and respiratory syncytial virus (RSV) cause substantial mortality from respiratory and other causes in the USA, especially among people aged 65 and older.
We estimated the influenza-attributable mortality and RSV-attributable mortality in the USA, stratified by age and risk status, using outcome definitions with different sensitivity and specificity.
Influenza- and RSV-associated mortality was assessed from October 1997-March 2009 using multiple linear regression modeling on data obtained from designated government repositories.
The main outcomes and measures included mortality outcome definitions-pneumonia and influenza, respiratory broad, and cardiorespiratory disease. A seasonal average of 10,682 (2287-16,363), 19,100 (4862-29,245), and 28,169 (6797-42,316) deaths was attributed to influenza for pneumonia and influenza, respiratory broad, and cardiorespiratory outcome definitions, respectively. Corresponding values for RSV were 6211 (4584-8169), 11,300 (8546-14,244), and 17,199 (13,384-21,891), respectively. A/H3N2 accounted for seasonal average of 71% influenza-attributable deaths; influenza B accounted for most (51-95%) deaths during four seasons. Approximately 70% influenza-attributable deaths occurred in individuals ≥75 years, with increasing mortality for influenza A/H3N2 and B, but not A/H1N1. In children aged 0-4 years, an average of 97 deaths was attributed to influenza (A/H3N2 = 49, B = 33, A/H1N1 = 15) and 165 to respiratory broad outcome definition (RSV). Influenza-attributable mortality was 2.94-fold higher in high-risk individuals.
Influenza-attributable mortality was highest in older and high-risk individuals and mortality in children was higher than reported in passive Centers for Disease Control and Prevention surveillance. Influenza B-attributable mortality was higher than A in four of 12 seasons. Our estimates represent an updated assessment of influenza-attributable mortality in the USA.
在美国,流感和呼吸道合胞病毒(RSV)导致大量因呼吸系统疾病及其他病因引起的死亡,尤其是在65岁及以上人群中。
我们使用具有不同敏感性和特异性的结局定义,按年龄和风险状况对美国流感归因死亡率和RSV归因死亡率进行了估计。
采用多元线性回归模型,对1997年10月至2009年3月期间从指定政府资料库获取的数据进行分析,评估流感和RSV相关死亡率。
主要结局和测量指标包括死亡率结局定义——肺炎和流感、呼吸道综合疾病以及心肺疾病。对于肺炎和流感、呼吸道综合疾病以及心肺疾病结局定义,季节性平均分别有10,682例(2287 - 16,363例)、19,100例(4862 - 29,245例)和28,169例(6797 - 42,316例)死亡归因于流感。RSV的相应数值分别为6211例(4584 - 8169例)、11,300例(8546 - 14,244例)和17,199例(13,384 - 21,891例)。A/H3N2占季节性平均流感归因死亡的71%;在四个季节中,B型流感导致的死亡占多数(51% - 95%)。约70%的流感归因死亡发生在75岁及以上人群中,A/H3N2和B型流感的死亡率呈上升趋势,但甲型H1N1流感并非如此。在0至4岁儿童中,平均有97例死亡归因于流感(A/H3N2 = 49例,B = 33例,A/H1N1 = 15例),165例归因于呼吸道综合疾病结局定义(RSV)。高危个体的流感归因死亡率高出2.94倍。
流感归因死亡率在老年人和高危个体中最高,儿童中的死亡率高于疾病控制与预防中心被动监测报告的水平。在12个季节中的4个季节里,B型流感归因死亡率高于A型流感。我们的估计代表了对美国流感归因死亡率的最新评估。